We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00779376
Recruitment Status : Completed
First Posted : October 24, 2008
Last Update Posted : October 24, 2008
Information provided by:
Ranbaxy Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2005
  Study Completion Date : April 2005